Emcure Pharmaceuticals (BOM:544210) LT-Debt-to-Total-Asset : 0.06 (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Emcure Pharmaceuticals's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.06.

Emcure Pharmaceuticals's long-term debt to total assets ratio declined from Sep. 2023 (0.12) to Sep. 2024 (0.06). It may suggest that Emcure Pharmaceuticals is progressively becoming less dependent on debt to grow their business.

Emcure Pharmaceuticals LT-Debt-to-Total-Asset Historical Data

The historical data trend for Emcure Pharmaceuticals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals LT-Debt-to-Total-Asset Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

0.12

0.14

0.13

Emcure Pharmaceuticals Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial			-	0.13	0.12	0.13	0.06

Emcure Pharmaceuticals LT-Debt-to-Total-Asset Calculation

Emcure Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	9823.36	/	78061.63
	=	0.13

Emcure Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	5003.18	/	81244.78
	=	0.06

Emcure Pharmaceuticals (BOM:544210) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Emcure Pharmaceuticals LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (BOM:544210) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

EMCURE:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines